Up date in the management of advanced ovarian carcinoma.
Conte
P F
PF
Department of Oncology, St. Chiara Hospital and University, Pisa, Italy. p.conte@do.med.unipi.it
Cianci
C
C
Gadducci
A
A
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D019772:Topotecan / Q000627:therapeutic use; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003841:Deoxycytidine; D019772:Topotecan; D000093542:Gemcitabine